Baird's Coldwell Responds To Walgreens/AmerisourceBergen Report, Tells Benzinga: 'I see the CVS-Aetna transaction as high-risk, high reward whereas the Walgreens-ABC transaction, if it were to come to fruition, I would see as low-risk, low reward'